GB0016052D0 - Ruthenium (II) compounds - Google Patents

Ruthenium (II) compounds

Info

Publication number
GB0016052D0
GB0016052D0 GBGB0016052.3A GB0016052A GB0016052D0 GB 0016052 D0 GB0016052 D0 GB 0016052D0 GB 0016052 A GB0016052 A GB 0016052A GB 0016052 D0 GB0016052 D0 GB 0016052D0
Authority
GB
United Kingdom
Prior art keywords
sup
compounds
ruthenium
cancer
saturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0016052.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Priority to GBGB0016052.3A priority Critical patent/GB0016052D0/en
Publication of GB0016052D0 publication Critical patent/GB0016052D0/en
Priority to EP01945472A priority patent/EP1294732B1/en
Priority to JP2002507824A priority patent/JP2004502696A/ja
Priority to BR0112122-7A priority patent/BR0112122A/pt
Priority to PT01945472T priority patent/PT1294732E/pt
Priority to ES01945472T priority patent/ES2227225T3/es
Priority to US10/312,940 priority patent/US6936634B2/en
Priority to AU2001267687A priority patent/AU2001267687A1/en
Priority to MXPA02012911A priority patent/MXPA02012911A/es
Priority to PCT/GB2001/002824 priority patent/WO2002002572A1/en
Priority to DE60105028T priority patent/DE60105028T2/de
Priority to AT01945472T priority patent/ATE273985T1/de
Priority to DK01945472T priority patent/DK1294732T3/da
Priority to CA002414446A priority patent/CA2414446A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0016052.3A 2000-06-30 2000-06-30 Ruthenium (II) compounds Ceased GB0016052D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB0016052.3A GB0016052D0 (en) 2000-06-30 2000-06-30 Ruthenium (II) compounds
CA002414446A CA2414446A1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer
US10/312,940 US6936634B2 (en) 2000-06-30 2001-06-26 Ruthenium (II) compounds for use in the therapy of cancer
MXPA02012911A MXPA02012911A (es) 2000-06-30 2001-06-26 Compuestos de rutenio (ii) para el uso en terapia del cancer.
BR0112122-7A BR0112122A (pt) 2000-06-30 2001-06-26 Composto de rutênio (ii) , uso de um composto, composição farmacêutica, método para tratar e/ou prevenir o câncer, e, processo para preparar um composto
PT01945472T PT1294732E (pt) 2000-06-30 2001-06-26 Compostos de rutenio (ii) para utilizacao na terapia do cancro
ES01945472T ES2227225T3 (es) 2000-06-30 2001-06-26 Compuestos de rutenio (ii) para utilizar en la terapia del cancer.
EP01945472A EP1294732B1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer
AU2001267687A AU2001267687A1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer
JP2002507824A JP2004502696A (ja) 2000-06-30 2001-06-26 癌治療用のルテニウム（ｉｉ）化合物
PCT/GB2001/002824 WO2002002572A1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer
DE60105028T DE60105028T2 (de) 2000-06-30 2001-06-26 Ruthenium (ii) verbindungen in der krebsbehandlung
AT01945472T ATE273985T1 (de) 2000-06-30 2001-06-26 Ruthenium (ii) verbindungen in der krebsbehandlung
DK01945472T DK1294732T3 (da) 2000-06-30 2001-06-26 Ruthenium (II)-forbindelser til anvendelse i cancerterapi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016052.3A GB0016052D0 (en) 2000-06-30 2000-06-30 Ruthenium (II) compounds

Publications (1)

Publication Number Publication Date
GB0016052D0 true GB0016052D0 (en) 2000-08-23

Family

ID=9894730

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0016052.3A Ceased GB0016052D0 (en) 2000-06-30 2000-06-30 Ruthenium (II) compounds

Country Status (14)

Country Link
US (1) US6936634B2 (enExample)
EP (1) EP1294732B1 (enExample)
JP (1) JP2004502696A (enExample)
AT (1) ATE273985T1 (enExample)
AU (1) AU2001267687A1 (enExample)
BR (1) BR0112122A (enExample)
CA (1) CA2414446A1 (enExample)
DE (1) DE60105028T2 (enExample)
DK (1) DK1294732T3 (enExample)
ES (1) ES2227225T3 (enExample)
GB (1) GB0016052D0 (enExample)
MX (1) MXPA02012911A (enExample)
PT (1) PT1294732E (enExample)
WO (1) WO2002002572A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1224192B1 (en) * 1999-10-27 2005-08-31 The University Court, The University Of Edinburgh Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
AU2002346686A1 (en) * 2001-12-07 2003-06-23 Intermune, Inc. Compositions and method for treating hepatitis virus infection
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds
AU2004234127A1 (en) 2003-04-30 2004-11-11 The University Court Of The University Of Edinburgh Ruthenium (II) complexes for the treatment of tumors
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
CN101851256B (zh) * 2010-04-30 2013-01-09 广东药学院 一种以柔性碳链联接的钌(ⅱ)卟啉配合物及其制备方法和应用
CN101863925B (zh) * 2010-05-21 2012-08-29 广东药学院 一种芳基钌(ⅱ)配合物及其制备方法和应用
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980472A (en) 1983-06-23 1990-12-25 American Cyanamid Company Method of making (3-amino-1H-pyrazol-4-yl) (aryl)methanones
AU570826B2 (en) 1984-07-24 1988-03-24 Asta-Pharma Aktiengesellschaft Ruthenium compounds having a tumor inhibiting activity
WO1986000804A1 (fr) 1984-07-24 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Compositions de ruthenium a effet inhibiteur de tumeurs
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
US5225556A (en) 1985-01-18 1993-07-06 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and for A-DNA; chiral metal complexes as Z-specific antitumor agents and as double strand cleavers
US4699978A (en) 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
AU4017695A (en) 1994-10-28 1996-05-23 Procept, Inc. Ruthenium complexes and their use as immunosuppressive agents
JPH11209314A (ja) 1997-09-30 1999-08-03 Takasago Internatl Corp シクロオクタジエン類の製造方法
JP3488103B2 (ja) * 1998-11-12 2004-01-19 高砂香料工業株式会社 ４−メチル−５−ヘキセン−１−アールを含有する香料組成物
GB0028025D0 (en) 2000-11-17 2001-01-03 Univ York Compounds

Also Published As

Publication number Publication date
DK1294732T3 (da) 2004-12-06
MXPA02012911A (es) 2004-07-30
US20040029852A1 (en) 2004-02-12
PT1294732E (pt) 2004-12-31
ES2227225T3 (es) 2005-04-01
BR0112122A (pt) 2003-05-13
US6936634B2 (en) 2005-08-30
JP2004502696A (ja) 2004-01-29
DE60105028D1 (de) 2004-09-23
WO2002002572A1 (en) 2002-01-10
ATE273985T1 (de) 2004-09-15
EP1294732A1 (en) 2003-03-26
DE60105028T2 (de) 2005-08-18
EP1294732B1 (en) 2004-08-18
CA2414446A1 (en) 2002-01-10
AU2001267687A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
ATE270817T1 (de) Fungizide
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
PL358281A1 (en) Novel compounds
SG152279A1 (en) Interfering rna duplex having blunt-ends and 3æ-modifications
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG106585A (en) Kinase inhibitors as therapeutic agents
GB0025173D0 (en) Therapeutic agents
AP2002002637A0 (en) Novel piperazine
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
IT1285770B1 (it) Composti corticoidei
NZ513096A (en) Compositions for treating inflammatory response
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
IL150125A0 (en) Novel compounds
AU2001267687A1 (en) Ruthenium (ii) compounds for use in the therapy of cancer
SE0003476D0 (sv) Compounds
GB0018951D0 (en) Novel compounds
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SI1532131T1 (sl) Motilidne spojine
GB0215526D0 (en) Anticancer compounds
HUT73529A (en) New bis-naphthalimides for the treatment of cancer
SE9903290D0 (sv) Novel compounds
GB0027705D0 (en) Novel compounds
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
PT1303520E (pt) Compostos terapêuticos e métodos
EP1889624A3 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)